IASLC/LinkedIn
Aug 8, 2025, 19:22
How AI is Being Applied to Clinical Trials – IASLC
International Association for the Study of Lung Cancer – IASLC shared on LinkedIn:
“Artificial intelligence has made headlines in every sector, but how is it shaping lung cancer research and care?
In this episode of Lung Cancer Considered, Dr. Stephen Liu speaks with Dr. Arsela Prelaj about how AI is being applied to clinical trials, diagnostics, biomarker analysis, and more.
Together, they explore the opportunities, the challenges, and the real-world impact of bringing AI into thoracic oncology.
More posts featuring IASLC.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 8, 2025, 21:29
Aug 8, 2025, 21:08
Aug 8, 2025, 20:54
Aug 8, 2025, 20:18
Aug 8, 2025, 20:03
Aug 8, 2025, 19:51
Aug 8, 2025, 19:34